Published in Arch Int Pharmacodyn Ther on February 01, 1968
Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage (2006) 1.77
Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum (1997) 1.64
Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis (2006) 1.59
Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum (2001) 1.35
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett (2002) 1.21
Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum (1999) 1.07
Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother (2000) 1.03
Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proc Natl Acad Sci U S A (1969) 1.00
Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. Osteoarthritis Cartilage (2004) 0.98
Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol (1997) 0.94
Hypotensive activity of PAF-acether in rats. Agents Actions (1982) 0.91
[Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men]. Ann Pharm Fr (1973) 0.91
Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes. Osteoarthritis Cartilage (2006) 0.91
The neuroleptics. 4. Toxicity and side effects in man and in the laboratory animal. Mod Probl Pharmacopsychiatry (1970) 0.89
Studies on the immunosuppressive activity of L-asparaginase. Recent Results Cancer Res (1970) 0.89
15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. FEBS Lett (2001) 0.88
[Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)]. Pathol Biol (1967) 0.88
Brain receptors and zopiclone. Pharmacology (1983) 0.87
Proteoglycan and collagen biochemical variations during fluoroquinolone-induced chondrotoxicity in mice. Antimicrob Agents Chemother (1999) 0.87
[Determination of (benzoyl-3 phenyl)-2 propionic acid or ketoprofen in biological media]. Ann Pharm Fr (1973) 0.87
Pharmacological studies on zopiclone. Pharmacology (1983) 0.87
Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepine binding to rat hippocampus photolabelled membranes. Biochem Pharmacol (1983) 0.85
Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum. J Neurochem (1983) 0.85
Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats. Arthritis Rheum (1999) 0.85
Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochem Pharmacol (2001) 0.84
Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs (1997) 0.83
Some pharmacological and toxicological studies on ketoprofen. Rheumatol Rehabil (1976) 0.82
Partial chemical characterization of cyclopyrrolones ([3H] suriclone) and benzodiazepines ([3H]flunitrazepam) binding site: differences. Life Sci (1985) 0.82
Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat. J Neuroendocrinol (2000) 0.82
Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems. Eur J Pharmacol (1984) 0.81
Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone. Pharmacol Biochem Behav (1985) 0.81
Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties--outline of toxicological and pharmacokinetic data. Scand J Rheumatol Suppl (1976) 0.81
Characterization of zymosan-induced arthritis in the rat: effects on joint inflammation and cartilage metabolism. Life Sci (1994) 0.81
Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs. J Clin Invest (1991) 0.80
omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. J Med Chem (1992) 0.80
In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci (1979) 0.80
[Resorption, excretion and biotransformation in dogs and rabbits, biotransformation in man of (methyl-10 phenothiazinyl-2) acetic acid (methiazinic acid--16091 R. P)]. Arzneimittelforschung (1969) 0.79
[Activity on Trichomonas vaginalis and other chemotherapeutic properties of 1-(2-hydroxyethyl)-2-carbamoyl-5-nitropyrrole (15,960 RP)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.79
Biotelemetry: an original approach to experimental models of inflammation. Inflamm Res (1999) 0.79
Brain receptors and zopiclone. Int Pharmacopsychiatry (1982) 0.78
Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics. Brain Res (1976) 0.78
A novel method for the sampling of synovial fluid in mice. Assay of a synovial lysosomal enzyme in zymosan-induced arthritis. Agents Actions (1988) 0.78
[Study of the pharmacological properties of 3-dimethylsulfonamido 10-(2-dimethylamino-propyl) phenothiazine (8.599 RP)]. Arch Int Pharmacodyn Ther (1966) 0.78
Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Br J Pharmacol (1998) 0.78
Lesions of the afferent catecholaminergic pathways inhibit the temporal activation of the CRH and POMC gene expression and ACTH release induced by human interleukin-1beta in the male rat. Neuroendocrinology (1995) 0.77
[Structure of griselimycin, polypeptide antibiotic extracted from streptomyces cultures. II. Structure of griselimycin]. Bull Soc Chim Fr (1971) 0.77
Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors. J Med Chem (1990) 0.77
Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone. Neuroendocrinology (1997) 0.77
Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor. J Interferon Cytokine Res (1996) 0.76
[Interleukin-1 and regulation of glucose homeostasis]. Pathol Biol (Paris) (1993) 0.76
Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.76
Metabolic investigations on pristinamycin. Nature (1965) 0.76
The role of 3D-microscopy in the study of chondrocyte-matrix interaction (alginate bead or sponge, rat femoral head cap, human osteoarthritic cartilage) and pharmacological application. Biorheology (2000) 0.76
[Structure of griselimycin, polypeptide antibiotic extracted Streptomyces cultures. I. Identification of the products liberated by hydrolysis]. Bull Soc Chim Fr (1971) 0.75
Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor. Mol Med (1997) 0.75
[Toxicologic study of methiazinic acid (16091 R.P)]. Arzneimittelforschung (1969) 0.75
Relationship between the inhibitory activity on 'RCS' and prostaglandins synthesis and the anti-inflammatory activity of ketoprofen and several other non-steroidal anti-inflammatory agents. Rheumatol Rehabil (1976) 0.75
Pharmacological studies on zopiclone. Int Pharmacopsychiatry (1982) 0.75
[Current concepts of various aspects of the pharmacology of neuroleptics]. Laval Med (1970) 0.75
Anti-inflammatory properties of IL-1 in carrageenan-induced paw oedema. Agents Actions (1994) 0.75
Pro- and anti-inflammatory properties of human recombinant IL-1 beta during experimental arthritis in rats: 2. Period-dependent effect. Life Sci (1993) 0.75
[General pharmacological properties of methiazinic acid (16091 RP)]. Arzneimittelforschung (1969) 0.75
[Experimental study of delayed-action injectable neuroleptics]. Actual Pharmacol (Paris) (1972) 0.75
The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--I. In vitro studies. Biochem Pharmacol (1980) 0.75
Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters. Acta Psychiatr Scand Suppl (1973) 0.75
omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. J Med Chem (1992) 0.75
[Anti-inflammatory proprieties of (10-methyl 2-phenothiazinyl) acetic acid (16, 091 R.P.)]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.75
High speed liquid-solid chromatography of phenothiazines using columns packed with spherosil porous silica beads. J Chromatogr Sci (1975) 0.75
Neurophysiological basis for neurogenic-mediated articular cartilage anabolism alteration. Am J Physiol Regul Integr Comp Physiol (2001) 0.75
[Acid derivatives of phenothiazine. Preparation and study of relations between the chemical structure and anti-inflammatory action]. Arzneimittelforschung (1969) 0.75
[Resorption, urinary excretion and biotransformation of 2,4,6-trihydroxyphenyl-propanone (florpropione)]. Therapie (1968) 0.75
Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems. Brain Res (1975) 0.75
[Biotransformation of metapramine in three animal species (dog, rabbit, rat) and in man]. Therapie (1982) 0.75
Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats. Osteoarthritis Cartilage (1999) 0.75
Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons. Adv Biochem Psychopharmacol (1977) 0.75
An approach to "middle molecules" identification in artificial kidney dialysate, with reference to neuropathy prevention. Trans Am Soc Artif Intern Organs (1973) 0.75
[A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). 3. Toxicological and pharmacological study]. Arzneimittelforschung (1967) 0.75
Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats. J Pharmacol Exp Ther (1989) 0.75
[Not Available]. C R Seances Soc Biol Fil (1958) 0.75
[Detection of kanamycin B in kanamycin by thin layer chromatography]. J Chromatogr (1973) 0.75
The neuroleptics. 3. Pharmacology. Introduction. Mod Probl Pharmacopsychiatry (1970) 0.75
Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--II. In vivo studies. Biochem Pharmacol (1980) 0.75
[Correlations between the results of pharmacokinetic and pharmacological studies on several pipotiazine esters]. Therapie (1974) 0.75
[Antiarrhythmic properties of 3-(2-hydroxy-3 isopropylamino-propoxy)-3 phenyl-2 isoindolinone-1, (RS, SR) in the dog]. C R Seances Acad Sci D (1979) 0.75
[Study of products excreted in the urine after pristinamycin ingestion]. Therapie (1966) 0.75
Lack of effect of interleukins 1 alpha and 1 beta, during in vitro perifusion, on anterior pituitary release of adrenocorticotropic hormone and beta endorphin in the male rat. J Neurosci Res (1993) 0.75
[Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives]. Presse Med (2000) 0.75
[Study of teratogenic acitivity of sodium oxyferriscorbone]. Ann Pharm Fr (1969) 0.75
[Therapy of hypersomnia]. Rev Neurol (Paris) (1967) 0.75
RP 54745, a potential antirheumatic compound. II. In vivo properties in different animal models. Agents Actions (1992) 0.75
Zymosan-induced arthritis in rats. II. Effects of anti-inflammatory drugs. Life Sci (1995) 0.75
[Absorption, excretion and biotransformation of benzene sulfonamido-2-tertiobutyl-5-thiadiazole-1,3,4(desaglybuzole=7 891 R.P.)]. Therapie (1969) 0.75
[Resorption, excretion and biotransformation of 3-dimethylsulfamido-10-(2-dimethylaminopropyl)-phenothiazine (Dimetotiazine) in the rabbit and dog]. Therapie (1968) 0.75
On the interaction between neuroleptics and antiparkinson drugs. Mod Probl Pharmacopsychiatry (1970) 0.75
[Histochemical study of experimental gastric lesions induced by acetylsalicylic acid and other drugs in rats]. Laval Med (1966) 0.75
[Structure of griselimycin, polypeptide antibiotic extracted from streptomyces cultures. 3. Products related to griselimycin]. Bull Soc Chim Fr (1971) 0.75